Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$13.62+0.77 (+5.99%)
Close on Nov 18, 2026Market cap $182.28MP/E –Yield –
Anika Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Anika Therapeutics's pe ratio was 76.9× on Apr 29, 2022, against 18.9× a year earlier. Over the last 5 years it ranged from 15.3× to 116.1×, with a median of 24.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 76.9× | +36.1 |
| 2020 | Oct 30, 2020 | 40.8× | +17.0 |
| 2019 | Dec 31, 2019 | 23.8× | −2.5 |
| 2018 | Dec 31, 2018 | 26.3× | +0.9 |
| 2017 | Dec 29, 2017 | 25.3× | +4.3 |
| 2016 | Dec 30, 2016 | 21.0× | −0.2 |
| 2015 | Dec 31, 2015 | 21.2× | +4.3 |
| 2014 | Dec 31, 2014 | 16.9× | −13.6 |
| 2013 | Dec 31, 2013 | 30.5× | +16.7 |
| 2012 | Dec 31, 2012 | 13.8× | −5.4 |
| 2011 | Dec 30, 2011 | 19.2× | −1.6 |
| 2010 | Dec 31, 2010 | 20.8× | – |
See a number that looks wrong?